Hydroxychloroquine News and Research

RSS
Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA

Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

Tofacitinib safe and effective for patients with rheumatoid arthritis

Tofacitinib safe and effective for patients with rheumatoid arthritis

Researchers classify chronic ulcerative stomatitis as a new autoimmune disease

Researchers classify chronic ulcerative stomatitis as a new autoimmune disease

Combination of molecularly targeted cancer drug and anti-malarial drug stops tumor growth

Combination of molecularly targeted cancer drug and anti-malarial drug stops tumor growth

Glasgow Professor discusses about new approach for CML treatment at UK conference

Glasgow Professor discusses about new approach for CML treatment at UK conference

Malaria drug shrinks, slows resistant pancreatic tumors

Malaria drug shrinks, slows resistant pancreatic tumors

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

CINJ clinical trial explores anti-malaria drug against melanoma

CINJ clinical trial explores anti-malaria drug against melanoma

Combination treatment with methotrexate and prednisone achieves remission in newly-developed RA

Combination treatment with methotrexate and prednisone achieves remission in newly-developed RA

Hydroxychloroquine may reduce cardiac neonatal lupus in subsequent pregnancies: Research

Hydroxychloroquine may reduce cardiac neonatal lupus in subsequent pregnancies: Research

DMARDs should be used early and aggressively at the first sign of RA: Researchers

DMARDs should be used early and aggressively at the first sign of RA: Researchers

Cancer Institute of New Jersey investigators target autophagy

Cancer Institute of New Jersey investigators target autophagy

CINJ trial targets new combination therapy for advanced solid tumors

CINJ trial targets new combination therapy for advanced solid tumors

CINJ researchers test malaria drug for colorectal cancer treatment

CINJ researchers test malaria drug for colorectal cancer treatment

Malaria medication hydroxychloroquine prevents diabetes in arthritis patients

Malaria medication hydroxychloroquine prevents diabetes in arthritis patients

Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Hydroxychloroquine may reduce risk of diabetes in patients with rheumatoid arthritis

Hydroxychloroquine may reduce risk of diabetes in patients with rheumatoid arthritis